Health Care • Medical/Dental Instruments
$416.67 ▲ +13.03
(+3.23%)
MKT CAP: $29.32B • VOL: 1.87M
52W L $224 52W H $438
CONSENSUS RATING DISTRIBUTION (40 DESKS)
BUY: 30 HOLD: 8
SELL: 2
12M STREET TARGET RANGE
IMPLIED: +14.0%
LOW
$350
MEDIAN
$467
MEAN
$475
HIGH
$567
STREET BS CREDIBILITY SCORE 1Y BACKTESTED
68/100
EMPIRICAL HIT RATE VS SPOT
GRADES WHETHER SELL-SIDE TARGET REVISIONS LEAD OR CHASE WST TAPE
WST // FIRM-BY-FIRM ANALYST BACKTEST & BS DETECTOR (ANR <GO>)
CURRENT 90D STREET CONSENSUS
| INSTITUTION / ANALYST | ACTION | RATING | TARGET | PRIOR PT | CALL DATE | PX AT CALL | RET SINCE CALL | 1Y ACCURACY | BS GRADE |
|---|---|---|---|---|---|---|---|---|---|
| Morgan Stanley Institutional Equity Desk | REITERATE | OUTPERFORM | $504.17 | $479.17 | 2025-02-14 | $379.17 | +9.9% | 78% | A |
| Goldman Sachs Global Research Sector Coverage | TARGET REV | STRONG BUY | $525.00 | $491.67 | 2025-02-06 | $391.67 | +6.4% | 74% | A |
| J.P. Morgan Securities US Large Cap | REITERATE | BUY | $475.00 | $458.34 | 2025-01-29 | $400.00 | +4.2% | 67% | B |
| Bernstein Autonomous Forensic Coverage | INITIATE | HOLD | $425.00 | — | 2025-01-17 | $408.34 | +2.0% | 61% | B |
| Barclays Capital Americas Research | DOWNGRADE | UNDERPERFORM | $366.67 | $395.84 | 2025-01-09 | $370.84 | -11.2% | 42% | D |
| UBS Investment Bank Institutional Desk | UPGRADE | BUY | $495.84 | $433.34 | 2024-12-18 | $362.50 | +14.9% | 72% | A |
| Citigroup Global Markets Sector Lead | TARGET REV | HOLD | $404.17 | $420.84 | 2024-12-04 | $387.50 | -4.3% | 48% | C |